Financial Performance - Net revenues decreased by $91,000 or 3%, from $2,663,000 to $2,572,000 for the three months ended March 31, 2023, compared to the same period in 2022[79]. - Gross profit increased by $165,000 to $1,105,000, representing 43% of net revenues for the three months ended March 31, 2023, up from 35% in the prior year[81]. - Selling, general and administrative expenses rose by $151,000 or 9%, totaling $1,844,000 for the three months ended March 31, 2023, driven by CDMO facility expenses[82]. - Research and development expenses decreased by $150,000 or 33%, amounting to $306,000 for the three months ended March 31, 2023[83]. - Interest expense surged by $3,080,000 to $3,903,000 for the three months ended March 31, 2023, primarily due to additional amortization expenses related to convertible notes[84]. Cash Position - Cash and cash equivalents increased to $5,854,000 as of March 31, 2023, compared to $4,177,000 at December 31, 2022[86]. Capital and Funding - The company raised approximately $2.6 million through a private placement of common stock and warrants on March 20, 2023[87]. - The company anticipates needing additional capital to fund operations and grow its business, raising concerns about its ability to continue as a going concern[88]. Business Development - The company plans to complete its new CDMO facility in 2023, which will include 12 class-7, ReadyStart cGMP Suites[75]. - The company is developing a proprietary manufacturing platform for cell manufacturing activities as part of its CDMO business expansion[74].

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call Webcast to review Financial and Operating Results for the Year Ended December 31, 2022. [Operator Instructions] As a reminder, this conference call ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-16375 ThermoGenesis Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 9 ...

ThermoGenesis Holdings, Inc. (OTCPK:THMO) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to Review Financial and Operating Results for the Third Quarter Ended September 30, 2022. As a reminder, all participants will be ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2022. or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition from _____________ to _______________. Commission File Number: 333-82900 ThermoGenesis Holdings, Inc. (Exact name of registrant as specified in its charter) De ...

ThermoGenesis Holdings, Inc. (OTCPK:THMO) Q2 2022 Results Conference Call August 11, 2022 3:00 PM ET Company Participants Paula Schwartz - Rx Communications Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to Review Financial and Operating Results for the Second Quarter Ended June 30, 2022. As a reminder, all participants will be in list ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2022. or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition from _____________ to _______________. Commission File Number: 333-82900 ThermoGenesis Holdings, Inc. (Exact name of registrant as specified in its charter) Large a ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2022. or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition from _____________ to _______________. Commission File Number: 333-82900 ThermoGenesis Holdings, Inc. (Exact name of registrant as specified in its charter) Delawa ...

ThermoGenesis Holdings, Inc. (OTCPK:THMO) Q1 2022 Earnings Conference Call May 19, 2022 4:30 AM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to review Financial and Operating Results for the First Quarter Ended March 31st, 2022. As a reminder, all participants will be in listen-only mode. There will be an ...

Thermogenesis Holdings, Inc. (OTCPK:THMO) Q4 2021 Earnings Conference Call March 28, 2022 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Chris Xu - CEO Jeff Cauble - CFO Conference Call Participants Sean Lee - H.C. Wainwright & Co. Operator Good day. And welcome to the ThermoGenesis Holdings Conference Call and Webcast to Review Financial and Operating Results for the Year-ended December 31, 2021. As a reminder all participants are in a listen-only mode. There will be an opportunit ...